News

Cyclical mastalgia can be adequately managed with first-line therapy including reassurance, physical support, flax seeds, and NSAIDs, with Tamoxi...

Stool gluten immunogenic peptide (GIP) assays are highly sensitive for monitoring gluten ingestion in coeliac disease, surpassing urine GIP asses...

Solar urticaria patients experience symptom improvement with Omalizumab, with high-affinity IgE receptor serving as a valuable predictor of treat...

Personalized prenatal iron supplementation, tailored to initial hemoglobin levels, is essential for optimal fetal development, as excessive doses...

In primary care settings, consideration should be given to employing the GerdQ algorithm for managing patients with gastroesophageal reflux-induc...

Lubiprostone, Linaclotide, and Elobixibat exhibit comparable efficacy in improving spontaneous bowel movements in patients struggling with chroni...

FDA has granted approval for Tirzepatide injection to mitigate chronic weight issues in adults battling obesity or overweight, along with at leas...

As per the FDA, the administration of probiotics formulated to contain live bacteria or yeast to preterm infants in hospital settings poses a sig...

WHO has updated its Essential Medicines List to include a range of essential multivitamins and micronutrient supplements for pregnant women, aimi...

For the management of multiple sclerosis, the FDA has granted approval to the first biosimilar (Natalizumab-sztn).

WHO has endorsed groundbreaking public health measures concerning novel Essential Medicines for the treatment of multiple sclerosis.

Zuranolone has received FDA approval for addressing postpartum depression in adults.